EcoDrugPlus

Ribosomal Protein L35a

Ensembl ID : ENSBBBG00000007879
Gene Symbol: RPL35A
3 Cross references
218 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSBBBG00000021559
Gene Symbol: RPL36
2 Cross references
168 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSBBBG00000007752
Gene Symbol: RPL37
3 Cross references
164 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSBBBG00000009773
Gene Symbol: RPL37A
3 Cross references
108 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSBBBG00000023033
Gene Symbol: RPL38
3 Cross references
236 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSBBBG00000009410
Gene Symbol: RPL4
3 Cross references
282 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSBBBG00000013558
Gene Symbol: RPL6
2 Cross references
394 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSBBBG00000000682
Gene Symbol: RPL7
2 Cross references
298 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSBBBG00000013398
Gene Symbol: RPL8
2 Cross references
268 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSBBBG00000000823
Gene Symbol: RPL9
2 Cross references
179 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSBBBG00000003090
Gene Symbol: RPS10
3 Cross references
283 Possible Orthologues:

Ribosomal Protein S11

Ensembl ID : ENSBBBG00000000112
Gene Symbol: RPS11
3 Cross references
197 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).